000 | 01519 a2200409 4500 | ||
---|---|---|---|
005 | 20250517185328.0 | ||
264 | 0 | _c20181213 | |
008 | 201812s 0 0 eng d | ||
022 | _a1896-494X | ||
024 | 7 |
_a10.13075/ijomeh.1896.01037 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhang, Hua | |
245 | 0 | 0 |
_aSubcutaneous administration of infliximab-attenuated silica-induced lung fibrosis. _h[electronic resource] |
260 |
_bInternational journal of occupational medicine and environmental health _cJul 2018 |
||
300 |
_a503-515 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBronchoalveolar Lavage Fluid _xchemistry |
650 | 0 | 4 |
_aI-kappa B Proteins _xgenetics |
650 | 0 | 4 |
_aInfliximab _xadministration & dosage |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 |
_aLung _xpathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNF-kappa B |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xgenetics |
650 | 0 | 4 |
_aPulmonary Fibrosis _xchemically induced |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 | _aSilicon Dioxide |
650 | 0 | 4 |
_aSilicosis _xprevention & control |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aSui, Jun-Na | |
700 | 1 | _aGao, Lei | |
700 | 1 | _aGuo, Jian | |
773 | 0 |
_tInternational journal of occupational medicine and environmental health _gvol. 31 _gno. 4 _gp. 503-515 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.13075/ijomeh.1896.01037 _zAvailable from publisher's website |
999 |
_c27815354 _d27815354 |